When used as monotherapy or in combination with metformin, the risk of clinically significant hypoglycemia is relatively low, typically less than five percent, due to the glucose-dependent nature of semaglutides insulin secretion
Forms of B12 supplements include cyanocobalamin and methylcobalamin tablets, sublingual preparations, sprays, and injectable hydroxocobalamin
Clean the injection site with an alcohol swab, pinch the skin to create a fold, insert the needle at a 45-90 degree angle, slowly inject the solution, then withdraw the needle and apply gentle pressure to the site
Contraindications Semaglutide methylcobalamin ODT should not be used by individuals with: Personal or family history of medullary thyroid carcinoma (MTC) Multiple endocrine neoplasia syndrome type 2 (MEN 2) Known hypersensitivity to semaglutide or any formulation component History of severe pancreatitis Severe gastrointestinal disease that may be worsened by delayed gastric emptying Severe renal impairment Pregnancy or planned pregnancy The methylcobalamin component has no meaningful contraindications at the doses used
